Literature DB >> 22968338

Mast cells and eosinophils are involved in activation of ulcerative colitis.

O Stasikowska-Kanicka1, M Danilewicz, A Głowacka, M Wągrowska-Danilewicz.   

Abstract

PURPOSE: The intestinal mucosal immune cells such as the mast cells and eosinophils play an important role in the pathogenesis of ulcerative colitis (UC). The aim of present study was to compare the number of mast cells and eosinophils in patients with active and non-active ulcerative colitis. Another purpose was to found whether the number of eosinophils could correlate with number of mast cells in both tested groups.
MATERIAL AND METHODS: The twenty-five of formalin-fixed, paraffin-embedded tissue specimens of active ulcerative colitis, the twenty of non-active ulcerative colitis and the ten of controls were retrieved from archival material. Tryptase and chymase immunopositive cells were detected using immunohistochemical method. Additionally, the number of mast cells and eosinophils were detected using the most common histochemical methods.
RESULTS: The number of eosinophils and toluidine blue stained and tryptase immunopositive mast cells was significantly increased in active UC compared to non-active UC. In active stage of UC positive correlation between the number of mast cells stained with toluidine blue and the number of chymase and tryptase immunopositive mast cells were observed. Moreover, the number of eosinophils was significantly correlated with number of mast cells stained with toluidine blue and number of tryptase- and chymase immunopositive mast cells. In non-active stage of UC positive correlation was observed only between the number of mast cells stained with toluidine blue and chymase immunopositive cells and eosinophils.
CONCLUSIONS: In conclusion, our findings confirmed that mast cells and eosinophils are functionally involved in the course of UC.

Entities:  

Mesh:

Year:  2012        PMID: 22968338     DOI: 10.2478/v10039-012-0029-3

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  9 in total

1.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

2.  Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn's disease tissue.

Authors:  Sibylle A Brenner; Steffi Zacheja; Michael Schäffer; Katharina Feilhauer; Stephan C Bischoff; Axel Lorentz
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

Review 3.  Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis.

Authors:  Diana Muñoz-Mendoza; Adrián Chapa-Rodríguez; Sami L Bahna
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

4.  Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Authors:  Erin M Kim; Cara Randall; Renee Betancourt; Staci Keene; Amy Lilly; Mark Fowler; Evan S Dellon; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

5.  Mast cells in the colon of Trypanosoma cruzi-infected patients: are they involved in the recruitment, survival and/or activation of eosinophils?

Authors:  Patrícia Rocha Martins; Rodolfo Duarte Nascimento; Júlia Guimarães Lopes; Mônica Morais Santos; Cleida Aparecida de Oliveira; Enio Chaves de Oliveira; Patrícia Massara Martinelli; Débora d'Ávila Reis
Journal:  Parasitol Res       Date:  2015-02-25       Impact factor: 2.289

6.  Identification of diagnostic signatures in ulcerative colitis patients via bioinformatic analysis integrated with machine learning.

Authors:  Jiajie Lu; Zhiyuan Wang; Munila Maimaiti; Wenjia Hui; Adilai Abudourexiti; Feng Gao
Journal:  Hum Cell       Date:  2021-11-03       Impact factor: 4.174

Review 7.  Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.

Authors:  Hiroyuki Ogasawara; Masato Noguchi
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

8.  Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis.

Authors:  Joanne C Masterson; Eóin N McNamee; Sophie A Fillon; Lindsay Hosford; Rachel Harris; Shahan D Fernando; Paul Jedlicka; Ryo Iwamoto; Elizabeth Jacobsen; Cheryl Protheroe; Holger K Eltzschig; Sean P Colgan; Makoto Arita; James J Lee; Glenn T Furuta
Journal:  Gut       Date:  2014-09-10       Impact factor: 23.059

Review 9.  Cellular Energetics of Mast Cell Development and Activation.

Authors:  Ryan P Mendoza; Dylan H Fudge; Jared M Brown
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.